{
    "title": "Russia approves second Covid-19 vaccine after early trials and claim it offers immunity from the virus for up to six months",
    "url": "https://www.dailymail.co.uk/news/article-8840719/Russia-approves-2nd-virus-vaccine-early-trials.html",
    "date": "2020-10-14",
    "keywords": [
        "vaccine",
        "coronavirus",
        "russia",
        "putin",
        "v",
        "sputnik",
        "use",
        "mass",
        "news",
        "testing",
        "wednesday",
        "jab",
        "epivaccorona",
        "response",
        "head",
        "safety",
        "test",
        "public",
        "share",
        "case",
        "day",
        "government",
        "month",
        "number",
        "earlystage",
        "protectionvladimir",
        "tv",
        "address",
        "nation",
        "minister",
        "tatyana",
        "golikova",
        "consumer",
        "watchdog",
        "group",
        "image",
        "protection",
        "monthswe",
        "production",
        "priority",
        "marketthe",
        "placerussia",
        "time",
        "home",
        "france",
        "germany",
        "record",
        "article",
        "september",
        "place",
        "november",
        "approach",
        "europe",
        "skepticism",
        "data",
        "company",
        "futurerussias",
        "gamaleya",
        "institute",
        "aug",
        "television",
        "side",
        "vaccinerussia",
        "effectiveness",
        "safetykirill",
        "investment",
        "fund",
        "effort",
        "india",
        "brazil",
        "approval",
        "assembly",
        "sputnikv",
        "staff",
        "offer",
        "demand",
        "caseload",
        "outbreak",
        "country",
        "summer",
        "health"
    ],
    "category": [
        "news"
    ]
}